Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.900
+0.060 (2.11%)
At close: Oct 9, 2026, 4:00 PM EDT
2.932
+0.032 (1.10%)
Pre-market: Oct 12, 2026, 7:22 AM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $445.38 million as of October 9, 2026. It is the 15,700th most valuable company in the world and the 2,847th biggest in the United States. Its market cap has increased by 19.34% in one year.
Market Cap
445.38M
Enterprise Value
249.25M
1-Year Change
19.34%
Global Rank
Country Rank
#2,847 United States
Category
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $445.38M, a decrease of -31.45%. That is a compound annual growth rate of -3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 445.40M | 122.59% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 480.43M |
| Assembly Biosciences | 479.08M |
| YD Bio | 476.69M |
| Entera Bio | 460.56M |
| Tectonic Therapeutic | 456.09M |
| Capricor Therapeutics | 455.23M |
| Prothena Corporation | 453.82M |
| DiaMedica Therapeutics | 449.20M |